Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: January 2008

Estelle

01 January 2008 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport: Permitted Active ingredient: Ethinylestradiol 30μg, gestodene 75μg. Description: White, round, biconvex sugar coated tablets. Presentation: 3 × 21, €7.60. Indications: Oral contraception.... Read more

Moxifloxacin (Avelox) & Hepatic Failure and Serious Skin Reactions

01 January 2008 | Irish Medicines Board

Important Safety Information Moxifloxacin (Avelox) & Hepatic Failure and Serious Skin Reactions Moxifloxacin (Avelox) is an antibacterial medicine authorised in Ireland for the treatment of the following bacterial infections: Acute exacerbation of chronic bronchitis Community acquired pneumonia, except severe cases... Read more

Information for Pharmaceutical Companies

01 January 2008 |

Policy Product inclusion Drugs can be included in MIMS Ireland if they have a Product Authorisation number (PA number) and therefore have an SPC or unlicensed drugs that are GMS/HT reimbursable. Currently, MIMS Ireland only includes branded generic drugs and... Read more

Mircera

01 January 2008 | New Products

Company: Roche Products (Ireland) Ltd. Legal category: Prescription. HT. Sport: Prohibited. Active ingredient: Methoxy polyethylene glycol-epoetin beta 50, 75, 100, 150, 200 and 250μg solution in 0.3ml. Description: Solution for injection in a pre-filled syringe. Presentation: Pack of 1 pre-filled... Read more

Perdamel

01 January 2008 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport: Permitted Active ingredient: Risperidone 0.5mg, 1mg, 2mg, 3mg, 4mg, 6mg. Description: Brownish-red/white/salmon/yellow/light green or yellow film-coated tablets debossed R and 0.5, 1, 2, 3, 4, 6 respectively. 0.5mg, 1mg, 2mg, 3mg... Read more

Navelbine

01 January 2008 | New Products

Company: Pierre Fabre Ltd. Legal category: Prescription. HT. Sport: Permitted Active ingredient: Vinorelbine 20mg, 30mg. Description: Light brown and pink soft capsule printed N20 and N30, respectively. Presentation: 20mg-1, €65.93; 30mg-1, €98.89. Indications: Treatment of non small cell lung cancer... Read more

Ceftal 125mg

01 January 2008 | New Presentations

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Cefuroxime 125mg equivalent to 150.36mg of cefuroxime axetil. Description: White to slightly yellowish, biconvex, oblong, coated tablets. Presentation: 14, €6.18. Indications: Treatment of mild to moderately severe infections caused... Read more

Actonel Plus Ca & D

01 January 2008 | New Presentations

Company: Procter & Gamble Pharmaceuticals UK Ltd/sanofi-aventis. Legal category: Prescription. GMS.2. Active ingredient: Tablet contains risedronate sodium 35mg (equivalent to 32.5mg risedronic acid). Effervescent granules contains calcium carbonate 2500mg (equivalent to calcium 1000mg and colecalciferol (vitamin D3) 22mcg (880 IU)).... Read more

Revlimid

01 January 2008 | New Products

Company: Celgene UK and Ireland Ltd. Legal category: Prescription. HT. Sport permitted. Active ingredient: Lenalidomide 5mg, 10mg, 15mg, 25mg. Description: Capsules marked REV followed by strength. 5mg, white; 10mg, blue-green/pale yellow; 15mg, pale blue/white; 25mg, white. Presentation: 5mg-21, €6085.80; 10mg-21,... Read more

Fosavance 70mg/5600 IU

01 January 2008 | New Presentations

Company: Merck Sharp & Dohme Ireland (Human Health) Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Alendronic acid 70mg (as alendronate sodium trihydrate) and colecalciferol (vitamin D3) 140mcg (5600 IU). Description: Modified rectangle-shaped, white to off-white tablets, marked with... Read more

Nexavar New Indication

01 January 2008 | New Clinical Evidence

Nexavar Approved in Europe for the Treatment of Patients with Hepatocellular Carcinoma Bayer Schering Pharma wish to announce that Nexavar (sorafenib) has been approved in Europe for the treatment of Hepatocellular Carcinoma (HCC).... Read more

Rasilez

01 January 2008 | New Products

Company: Novartis Ireland Ltd. Legal category: Prescription. GMS. SPORT: Permitted. Active ingredient: Aliskiren 150mg, 300mg. Description: Biconvex film-coated tablets marked NVR on one side. 150mg: Light-pink, round marked IL on reverse. 300mg: Light red, ovaloid marked IU on reverse. Presentation:... Read more

Spiriva Respimat

01 January 2008 | New Presentations

Prescription. GMS. Sport Permitted. Boehringer Ingelheim and Pfizer Healthcare are pleased to announce the introduction of Spiriva Respimat this month. The Respimat Soft Mist Inhaler is a new delivery device for Spiriva (tiotropium bromide).... Read more

New Data Supporting Efficacy of Spiriva Respimat

01 January 2008 | New Clinical Evidence

Data Support similar Efficacy in COPD Patients of Tiotropium Administered via the Respimat Soft MistTM Inhaler compared with HandiHaler - Boehringer Ingelheim and Pfizer Healthcare wish to announce the introduction of Spiriva Respimat which uses Respimat Soft Mist Inhaler as... Read more

News from the World Anti-Doping Agency

01 January 2008 | New this Month

Changes to Prohibited List announced by World Anti-Doping Agency - The World Anti-Doping Agency (WADA) has issued a new Prohibited List of Substances and Methods which comes into effect on 1 January 2008. Changes to the Prohibited List are as... Read more

New Formulation of Protamine Sulphate

01 January 2008 | New this Month

Launch of Protamine Sulphate 1400 anti heparin IU/ml solution for injection - LEO Pharma is pleased to announce the launch of a new formulation, Protamine Sulphate LEO Pharma 1400 anti heparin IU/ml solution for injection which will be available from... Read more

Withdrawal of Agenerase Oral Solution

01 January 2008 | Discontinued Products

GlaxoSmithKline wish to inform you of their intended withdrawal of Agenerase Oral Solution from the Irish Market from February 2008. Stock will continue to be available until 28th February 2008. The therapeutic alternative to Agenerase Oral Solution will continue to... Read more

Notice of discontinuation of Eprex 40,000 IU/ml

01 January 2008 | Discontinued Products

Janssen-Cilag Ltd. wish to announce that Eprex (epoetin alfa) 40,000 IU/ml solution for injection in 1ml vials are no longer marketed in both the UK and Ireland and currently have no stock left in supply.... Read more

Notice of discontinuation of Fansibar 500mg/25mg

01 January 2008 | Discontinued Products

As part of a regular review of products in its pharmaceutical portfolio, Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Fansidar 500mg/25mg tablets (pack of 3).... Read more

Products withdrawn in Ireland in the last 12 months

01 January 2008 | Discontinued Products

The majority of withdrawals have been due to commercial rationalisation decisions. Products highlighted in bold apply to the current month.... Read more